On Monday, Prologis Inc (NYSE:PLD)’s shares inclined 1.34% to $40.12.
Prologis Inc (PLD) declared it has received commitments for more than ¥55 billion (about $455 million) unsecured senior term loan facility.
The yen-denominated facility will mature in 2022. As of May 21, 2015, the weighted average interest rate would be about 1.2% based on Japanese LIBOR plus 110 basis points at the company’s current credit rating. The facility is predictable to close in June and is subject to customary closing conditions.
The facility will be the company’s third noteworthy capital markets transaction since its April 2015 declarement of a definitive agreement to acquire the assets of KTR Capital Partners and its associates. The cumulative principal amount of the three financing transactions will total more than $2.2 billion with a weighted average rate of about 1.3% under the applicable LIBOR rates as of May 21, 2015 and a weighted average term of 4.8 years assuming the exercise of extensions at Prologis’ option.
Prologis Inc. is an independent equity real estate investment trust. It invests in the real estate markets across the globe. The firm engages in the ownership, development, administration, and leasing of industrial distribution and retail properties. It was formerly known as Security Capital Investment Trust. Prologis Inc. was formed in 1991 and is based in San Francisco, California with an additional office in Denver, Colorado.
PG&E Corporation (NYSE:PCG)’s shares gained 0.36% to $53.66.
PG&E Corporation (PCG) declared the open application period of its Economic Vitality Grant Program. In its third year, the utility’s economic development effort provides a total of up to $200,000 to deserving local government organizations, educational institutions and 501(c) 3 nonprofit organizations to fund projects or programs designed to spur innovation and job creation.
As part of PG&E’s nearly $2.5 million charitable commitment to economic vitality in 2015, this shareholder-funded program will invest in local initiatives that aim to attract, retain or expand local businesses; provide business development, incubation or acceleration opportunities; or provide valuable workforce training. The community need for job creation and economic opportunity will be a strong factor when considering grant applications.
Applications for PG&E’s Economic Vitality Grant Program will be accepted from recently through July 31, 2015. To learn more and apply, visit www.pge.com/evgrants.
PG&E Corporation, through its partner, Pacific Gas and Electric Company, transmits, delivers, and sells electricity and natural gas to residential, commercial, industrial, and agricultural customers primarily in northern and central California.
At the end of Monday’s trade, AstraZeneca plc (ADR) (NYSE:AZN)‘s shares dipped -0.75% to $67.04.
AstraZeneca plc (ADR) (AZN) declared preliminary efficacy and safety data for AZD9291 in the first-line treatment of epidermal growth factor receptor mutation positive (EGFRm) advanced non-small cell lung cancer (NSCLC). Data showed that 81% (95% confidence interval (CI) 68% to 89%) of patients on a once daily dose of AZD9291 were progression free at 9 months; overall response rate was 73% (95% CI 60% to 84%). The longest duration of response was ongoing at 13.8 months at the time of data cutoff.1
The data from the first-line expansion cohorts of the AURA Phase I study were presented at the annual meeting of the American Society of Clinical Oncology in Chicago. The first-line cohorts comprised of 60 patients with EGFRm advanced NSCLC who received AZD9291 80mg or 160mg once daily. The data are not fully mature with an approximate 11 month median follow up in the 80mg cohort, and an approximate 8.5 month median follow up in the 160mg cohort. The most common adverse events in both cohorts comprised of rash (Grade 3: 0% at 80mg, 3% at 160mg) and diarrhea (Grade 3: 0% at 80mg, 7% at 160mg).1
AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection, and neuroscience diseases worldwide.
United Technologies Corporation (NYSE:UTX), ended its Monday’s trading session with -0.10% loss, and closed at $117.05.
United Technologies Corporation (UTX) will broadcast its analysts and portfolio managers meeting at the Paris Air Show on Monday, June 15, 2015. The meeting is planned for 3:00 a.m. ET (9:00 a.m. local time in Paris). It will be broadcast live on the Internet at www.utc.com and will be archived on the website afterward. Corresponding presentations will be accessible on the site prior to the meeting.
United Technologies Corporation provides technology products and services to building systems and aerospace industries worldwide. Its Otis segment designs, manufactures, sells, and installs passenger and freight elevators, escalators, and moving walkways; modernization products to upgrade elevators and escalators; and maintenance and repair services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
